Latest News
Dr. Goodenowe presents at the Dementia Prevention Conference in Japan
Dr. Goodenowe, Founder of Prodrome Sciences, presented his research on plasmalogens and neurodegeneration and the strong clinical data supporting plasmalogen supplementation as a s
Major paper published demonstrating the role of plasmalogens in the cause of Alzheimer’s
Plasmalogen molecules, critical lipids required for brain and nerve function, have been researched extensively since Dr. Goodenowe (Founder and CEO, Prodrome Sciences) first publis
Dr. Goodenowe publishes research on the relationship between plasmalogens and the APOE e4 genotype
Dr. Goodenowe’s latest peer-reviewed published research shows that a person’s levels of plasmalogens, a critical lipid molecule required for brain and nerve function, i
Alzheimer’s Association funds plasmalogen clinical trial
Based upon Dr. Goodenowe’s research linking high plasmalogen levels with a low risk of Alzheimer’s disease, the Alzheimer’s Association (Chicago, USA) is funding a clini
Alzheimer’s research published
Dr. Goodenowe’s latest peer-reviewed publication is on research results from a community trial of 1,205 persons (average age = 84) that showed that elderly persons with high
Colorectal and pancreatic cancer biomarker study
Prodrome Sciences Inc.; Chiba University Hospital, Division of Clinical Mass Spectrometry; Chiba Cancer Center; and Chiba Foundation for Health Promotion & Disease Prevention a
3-year colorectal cancer program
Prodrome Sciences Inc.; Chiba University Hospital, Division of Clinical Mass Spectrometry; Chiba Cancer Center; and Chiba Foundation for Health Promotion & Disease Prevention h
New paper shows plasmalogen levels are lower in patients with bipolar disorder
Plasmalogens are critical molecules needed for optimal health and nerve and brain function. The role of plasmalogens in neurodegenerative diseases such as Alzheimer’s is well est
Biomarker discovery research on aging, dietary lifestyles, and disease
Prodrome Sciences and Kyoto Prefectural University of Medicine (Department of Epidemiology for Community Health and Medicine) are proud to announce they have begun a collaborative
